| pubmed-article:10696981 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10696981 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:10696981 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:10696981 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10696981 | lifeskim:mentions | umls-concept:C0011849 | lld:lifeskim |
| pubmed-article:10696981 | lifeskim:mentions | umls-concept:C0271650 | lld:lifeskim |
| pubmed-article:10696981 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:10696981 | pubmed:issue | 9204 | lld:pubmed |
| pubmed-article:10696981 | pubmed:dateCreated | 2000-3-22 | lld:pubmed |
| pubmed-article:10696981 | pubmed:abstractText | Growth hormone (GH) contributes to insulin resistance, but whether children treated with GH are at increased risk of diabetes has not been established. We undertook a retrospective analysis of data from an international pharmacoepidemiological survey of children treated with GH to find out the incidence of impaired glucose tolerance and types 1 and 2 diabetes mellitus. | lld:pubmed |
| pubmed-article:10696981 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10696981 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10696981 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10696981 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10696981 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10696981 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10696981 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10696981 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10696981 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10696981 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:10696981 | pubmed:issn | 0140-6736 | lld:pubmed |
| pubmed-article:10696981 | pubmed:author | pubmed-author:ChatelainPP | lld:pubmed |
| pubmed-article:10696981 | pubmed:author | pubmed-author:PriceD ADA | lld:pubmed |
| pubmed-article:10696981 | pubmed:author | pubmed-author:RankeM BMB | lld:pubmed |
| pubmed-article:10696981 | pubmed:author | pubmed-author:Albertsson-Wi... | lld:pubmed |
| pubmed-article:10696981 | pubmed:author | pubmed-author:WiltonPP | lld:pubmed |
| pubmed-article:10696981 | pubmed:author | pubmed-author:CutfieldW SWS | lld:pubmed |
| pubmed-article:10696981 | pubmed:author | pubmed-author:BennmarkerHH | lld:pubmed |
| pubmed-article:10696981 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10696981 | pubmed:day | 19 | lld:pubmed |
| pubmed-article:10696981 | pubmed:volume | 355 | lld:pubmed |
| pubmed-article:10696981 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10696981 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10696981 | pubmed:pagination | 610-3 | lld:pubmed |
| pubmed-article:10696981 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:meshHeading | pubmed-meshheading:10696981... | lld:pubmed |
| pubmed-article:10696981 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10696981 | pubmed:articleTitle | Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. | lld:pubmed |
| pubmed-article:10696981 | pubmed:affiliation | Department of Paediatrics, University of Auckland, New Zealand. waynec@ahsl.co.nz | lld:pubmed |
| pubmed-article:10696981 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10696981 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10696981 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10696981 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10696981 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10696981 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10696981 | lld:pubmed |
